Emerging evidence connects metabolic health with testosterone, while underscoring the importance of individualized evaluation.
AMERICAN FORK, Utah — October 5, 2026 — Can treating excess weight also improve low testosterone? Research presented at the Endocrine Society’s 2026 annual meeting is adding evidence to that question, with potential implications for men navigating obesity, hormone symptoms and fertility concerns. The findings point toward considering metabolic health alongside testosterone levels, rather than viewing the two as separate issues.
What the new research found
The ENDO 2026 review examined five randomized controlled trials involving GLP-1 treatments and male reproductive health. Some studies found improvements in testosterone or semen measures among men with obesity-related hormone deficiencies. However, the researchers described the evidence as limited and varied, and called for larger trials designed specifically to assess reproductive outcomes.
One small trial published in Diabetes, Obesity and Metabolism followed 25 men with obesity, type 2 diabetes and functional hypogonadism for 24 weeks. Participants received either semaglutide or testosterone replacement therapy. Both groups experienced higher total testosterone levels, while the semaglutide group also showed improvement in the proportion of normally shaped sperm.
The distinction matters: improvements in laboratory measurements are not the same as proof of improved fertility or successful pregnancy. The trial was small, involved a specific patient population and did not establish that weight-loss medication can replace testosterone therapy for all men. Sexual-function scores improved significantly only in the testosterone group.
Why the cause of low testosterone matters
In a July 16, 2026 statement, the Endocrine Society emphasized identifying the underlying cause before choosing treatment. When low testosterone is associated with excess weight and no other cause is identified, weight loss is typically the first-line approach. That differs from hypogonadism caused by disease affecting the testes, pituitary gland or hypothalamus, for which appropriately prescribed testosterone can offer clear benefits.
The practical takeaway is not that one medication is universally better. It is that two men with similar testosterone results may need different care. Symptoms, medical history, the reason hormone levels are low and personal goals all belong in that decision. Treating a number without understanding its context can miss the problem that needs attention.
Testing and fertility belong in the conversation
Fatigue, low libido and mood changes can have multiple causes. Current Endocrine Society guidance calls for compatible symptoms and consistently low testosterone, confirmed with repeat morning fasting testing, rather than relying on one result. Additional evaluation may help distinguish a testicular problem from changes involving the brain’s hormone-signaling system.
Men planning to have children should discuss that goal before starting treatment. Testosterone therapy can suppress sperm production, and the Society recommends against starting it in men planning fertility in the near term. The emerging GLP-1 research makes fertility an important consideration, but does not establish these medications as proven infertility treatments.
What this means for men considering hormone care
For men exploring hormone replacement therapy in Utah, Hormone Balance Centers describes an evaluation process that includes symptoms, health history, appropriate laboratory testing and an individualized monitoring plan when treatment is prescribed. Its approach emphasizes that concerns such as fatigue or body-composition changes do not automatically mean hormone treatment is necessary.
Taken together, the evidence suggests a useful starting question: is low testosterone a condition requiring replacement, a sign of an underlying metabolic issue, or part of a more complex picture? A careful evaluation can help clarify the answer before treatment begins. The goal is appropriate care for the individual—not a universal testosterone target or a promise that weight loss will resolve every hormone concern.
